Pii-lba4 Terrain Trial: Prostate-specific Antigen Kinetics and Quality of Life Results of Enzalutamide Versus Bicalutamide in Metastatic Castration-resistant Prostate Cancer
Year: 2015
Type: article
Abstract: indeterminate PSA results who would be candidates for initial biopsy.The assay should result in a 27% reduction of prostate needle biopsies while missing only 5% of higher grade >/¼ 4+3 cancers.
Source: The Journal of Urology
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2143674813
